The understanding, diagnosis, and treatment options for transthyretin (TTR) amyloid is rapidly evolving. American Heart Association published a statement titled "Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association". I have tried to present the key elements of this article.  Link: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000792

Why we do what we do in Cardiology

Cardiac Amyloidosis-2020 Update

I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in the field of cardiology from past and present.

hubhopper

Why we do what we do in Cardiology

hubhopper